ePrints

A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

Lookup NU author(s): Dr Sally Hall

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Yip K, Conibear J, Woolf D, Tarver K, Willis B, Hall S, Sun F, Kuhan H, Lambourne B, Piskilidis P, Kussaibati R, Martin L, Satar NA, Gray CMN, Khan A, Doherty G, Prewett S, Smith M, Dancey G, Patterson DM, Rimmer Y, Hollingdale A, Ingle C, Tasigiannopoulos Z, Aslam S, Waite K, Polychronis A, Ghafoor Q, Baijal S, Newsom-Davis T, Shah R, Forster M, Mulatero C, Greystoke A, Postmus PE, Blackhall F, Gilligan D

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Poster Abstracts of the 15 Annual British Thoracic Oncology Group Conference 2017

Year of Conference: 2017

Pages: S28-S29

Print publication date: 01/01/2017

Online publication date: 09/02/2017

Acceptance date: 02/04/2016

ISSN: 0169-5002

Publisher: Elsevier Ireland

URL: https://doi.org/10.1016/S0169-5002(17)30112-5

DOI: 10.1016/S0169-5002(17)30112-5

Series Title: Lung Cancer

Share